FocusFragile X Syndrome

Clinical trials for neurodevelopmental disorders: At a therapeutic frontier

See allHide authors and affiliations

Science Translational Medicine  13 Jan 2016:
Vol. 8, Issue 321, pp. 321fs1
DOI: 10.1126/scitranslmed.aad9874

Article Information

vol. 8 no. 321 321fs1

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Shafali S. Jeste1 and
  2. Daniel H. Geschwind2,*
  1. 1Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA 90095-17610, USA.
  2. 2Center for Autism Research and Treatment, Semel Institute, and Neurogenetics Program, Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-1761, USA.
  1. *Corresponding author. E-mail: dhg{at}mednet.ucla.edu (D.H.G.)

Altmetric

Article usage

Article usage: January 2016 to August 2020

AbstractFullPdf
Jan 20162727355385
Feb 201642486105
Mar 20162865154
Apr 20161792564
May 20162514072
Jun 20161592327
Jul 20161041518
Aug 20161192327
Sep 20161231825
Oct 2016992220
Nov 2016136820
Dec 2016114625
Jan 2017108618
Feb 2017591919
Mar 201770510
Apr 201754714
May 201791812
Jun 20174746
Jul 201764139
Aug 20177458
Sep 201772610
Oct 20176485
Nov 20176241
Dec 20175424
Jan 20184135
Feb 20185745
Mar 20185422
Apr 20185986
May 20186932
Jun 201868610
Jul 20185464
Aug 20183547
Sep 20184074
Oct 20183195
Nov 201851134
Dec 201850122
Jan 20195095
Feb 20196487
Mar 201930134
Apr 20193852
May 20193174
Jun 201929113
Jul 20192395
Aug 20193832
Sep 20192033
Oct 201935114
Nov 20192112
Dec 20191864
Jan 202024100
Feb 20202656
Mar 20202786
Apr 20202263
May 20203987
Jun 20201932
Jul 20201300
Aug 2020615

Stay Connected to Science Translational Medicine